NEW YORK (GenomeWeb) – T2 Biosystems reported after the close of the market Tuesday that it took in no revenues for the third quarter ended Sept. 30.

In last year's third quarter, the firm recorded $91,000 in research and grant revenue.

Though T2 Bio did not record any revenues, its most recent quarter featured several important developments for the Lexington, Mass.-based molecular diagnostics firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.